NEW YORK, Dec. 04, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of SunEdison, Inc. (“SunEdison”) (NYSE:SUNE) between June 16, 2015 and October 6, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Eastern District of Missouri. If you purchased or otherwise acquired SunEdison securities between June 16, 2015 and October 6, 2015, your rights may be affected by this action.To get more information go to:
http://zlk.9nl.com/sunedison-sune
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that, among other allegations, SunEdison did not have the financial resources necessary to maintain its high growth and sustain its dividend. On October 5, 2015, the Company disclosed it was laying off 15% of its workforce. Upon this news, shares of SunEdison have declined sharply in value over the course of several disclosures regarding the Company’s financial condition, thereby injuring investors.
If you suffered a loss in SunEdison you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



